![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, March 26, 2015 11:39:06 AM
Bio, Wasn't March 2014 when we had those 2 36 mil days?
AtonewithPPHM
Yes... very true and I am just trying to dig deeper and out of the box to find out what other possibilities could have been set up at that time.
For one, I think Ben Kramer-Miller is part of it but like I said before... I check every single path and some lead no where and some surprisingly, connect in some way.
I don't believe Ben Kramer-Miller mentioned Peregrine Pharmaceuticals in his article for no reason at all and if XON is the stock to own for the next decade and if some with XON P53 etc knows that PS Targeting is required, maybe Ben Kramer-Miller should dig deeper and he may think that if XON is the stock to own for the next decade, then Peregrine Pharmaceuticals would be the stock to own for the next two decades or at minimum until PS Targeting patents begin to expire. Of course, by that time.... Peregrine and PS Targeting revenues will bring in much money in order to diversify in all directions outside of the traditional Big Pharma like business.
Ben Kramer-Miller Articles ... a reminder to all for the patent filing date and publication date:
Application Number:
14/204914
Publication Date:
02/12/2015
Filing Date:
03/11/2014
Full patent description:
http://investorshub.advfn.com/boards/replies.aspx?msg=112089063
Ben Kramer-Miller:
May 6, 2014
..
..
Regarding the second one, we know that Peregrine is working towards a cure for cancer. But will it find one? Even if it does, who’s to say that Peregrine will be first or that its cure will be accepted by the FDA? If you buy Peregrine shares based on the thesis I provide, and if you are right, you will probably make several multiples on your initial investment. But if Peregrine fails, then your investment goes to zero. Also keep in mind that you are not the only one betting one way or another on Peregrine’s success. What gives you an advantage over the scientists and doctors that the experts on Wall Street can easily afford to hire? The fact of the matter is that Peregrine is speculative — if you buy shares, you are betting that a future binary event will have a specific outcome.
http://www.cheatsheet.com/business/dont-gamble-with-your-future-invest-dont-speculate.html/?a=viewall
Feb 10, 2015
Miller also explains why he thinks Intrexon (XON) could be the stock to own for the next decade.
http://www.gurufocus.com/news/315541/bill-miller-identifies-what-could-be-the-stock-of-the-decade
--------------------------------------------------------
Time to connect some dots with Peregrine employees/KOL's , Sunil Chada and finance guys and BP affiliations and much more... unfortunately, I need to head back to California for the 2nd time in like 5 or 6 years and the posts will be short and sweet but getting closer.
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!
Recent CDMO News
- Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024 • GlobeNewswire Inc. • 07/02/2024 08:05:04 PM
- Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024 • GlobeNewswire Inc. • 07/01/2024 11:00:21 AM
- Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance • GlobeNewswire Inc. • 05/23/2024 12:05:46 PM
- Avid Bioservices to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 08:05:11 PM
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:38:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:37:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:36:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:35:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 12:56:02 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/08/2024 09:32:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:56:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:55:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:53:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:51:57 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM